Given that gastric tumors (especially malignant tumor types) have higher copper and lactate concentrations than normal tissues, treatment with copper ionophores to bind copper ions and SIRT2-specific inhibitor may serve as a feasible and available strategy for gastric cancer therapy. The gene discussed is SIRT2; the disease is cancer.